Ahmed Nadim

Ahmed Nadim is listed in filings as President and CEO at Cullinan Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 25, 2026, including sale activity. Recent filings connect the profile to Cullinan Therapeutics, Inc. (CGEM) and Disc Medicine, Inc. (IRON). The current snapshot covers public activity from Dec 27, 2024 to Feb 25, 2026. Reported amounts are shown as $195.6K to $10.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.